CSB(SZ:300718)2023-10-24 16:00Financial Performance - The company's operating revenue for Q3 2023 was CNY 284,275,862.25, representing a 4.59% increase year-over-year[3]. - Net profit attributable to shareholders for Q3 2023 was CNY 60,187,043.58, an increase of 13.81% compared to the same period last year[3]. - Basic earnings per share for Q3 2023 were CNY 0.20, reflecting an 80% increase year-over-year[3]. - Total operating revenue for Q3 2023 reached ¥819,429,713.03, an increase of 2.4% compared to ¥801,556,839.83 in Q3 2022[15]. - Net profit for Q3 2023 was ¥180,021,965.54, up 39% from ¥129,577,676.27 in the same period last year[16]. - Earnings per share increased to ¥0.60, compared to ¥0.44 in Q3 2022, reflecting a growth of 36.4%[16]. - The total comprehensive income for Q3 2023 was ¥179,531,199.20, compared to ¥129,443,778.71 in Q3 2022, reflecting an increase of approximately 38.7%[16]. Cash Flow and Liquidity - The net cash flow from operating activities reached CNY 196,266,502.54, showing a significant increase of 149%[3]. - The company reported a significant increase in cash flow from operations, contributing to improved liquidity and financial stability[12]. - Operating cash flow for the period reached ¥196,266,502.54, a significant increase from ¥78,741,460.31 in the previous period, reflecting a growth of approximately 149.9%[17]. - Total cash inflow from operating activities was ¥719,998,129.41, compared to ¥762,485,665.59 in the prior period, indicating a decrease of about 5.6%[17]. - Cash outflow from operating activities decreased to ¥523,731,626.87 from ¥683,744,205.28, a reduction of approximately 23.5%[17]. - The ending balance of cash and cash equivalents was ¥433,055,681.49, a significant increase from ¥64,828,066.38 at the end of the previous period[18]. Assets and Liabilities - Total assets as of September 30, 2023, amounted to CNY 1,810,683,599.00, a 7.28% increase from the end of the previous year[3]. - Total assets as of the end of Q3 2023 amounted to ¥1,810,683,599.00, up from ¥1,687,889,410.55 at the end of Q3 2022[14]. - Total liabilities increased to ¥240,677,477.54 from ¥231,064,588.23, marking a rise of approximately 4.0%[14]. - The company's equity attributable to shareholders rose to ¥1,479,920,723.13, compared to ¥1,365,442,951.55 in the previous year, an increase of about 8.4%[14]. Investments and Expenses - The company’s investment income decreased by 35.19% to CNY 13,001,486.45, attributed to reduced returns from financial product investments[7]. - Research and development expenses for Q3 2023 were ¥39,312,677.38, up from ¥36,478,797.07, indicating a growth of 7.5%[15]. - The company reported a decrease in financial expenses, with a net financial income of ¥5,104,827.75 compared to a loss of ¥3,154,725.06 in the previous year[15]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 11,032[8]. - The total number of restricted shares decreased to approximately 98.19 million from 102.74 million, following the release of 4.56 million shares during the period[11]. Future Outlook - The company plans to continue expanding its market presence and invest in new product development to drive future growth[12]. - The management highlighted ongoing efforts in research and development to enhance product offerings and maintain competitive advantage in the market[12]. Construction and Capital Expenditure - The company has initiated the construction of a new factory, leading to a 110.87% increase in construction in progress, totaling CNY 24,478,224.76[7].